Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Paratek Pharmaceuticals Inc.

www.paratekpharm.com

Latest From Paratek Pharmaceuticals Inc.

New Tech Payment For Old Antibiotic: US Medicare Effort Brings Lots Of Interest

CMS streamlined process for enhanced payments is having an impact: seven antibiotic applications for New Technology Add-On Payment status in 2021—including one for a product that has been marketed for more than five years.

Infectious Diseases Reimbursement

First Ebola Vaccine Among Seven Products To Get EMA Nod

Seven new products, including the world’s first ever Ebola vaccine, are on track to receive EU-wide approval. Meanwhile, two drugs have failed to make the grade.

Approvals Europe

All Or Nothing: Paratek Withdraws EU Filing For Nuzyra

A month after being asked to attend an oral explanation meeting with the European Medicines Agency, Paratek Pharmaceuticals has decided to withdraw the EU marketing application for its broad spectrum antibiotic, Nuzyra. The company is one of two drug sponsors that has withdrawn an EU marketing application in October.

Europe Drug Review

UK Pilots 'Revolutionary And Needed' Antibiotic Payment System

The UK National Health Service is to test the world's first ‘subscription’ payment model to tempt drug makers to develop new products for resistant infections.

United Kingdom Government Payers
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Transcept Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Paratek Pharmaceuticals Inc.
  • Senior Management
  • Evan Loh, MD, CEO
    Douglas P Pagan, CFO
    Adam Woodrow, Pres. & Chief Commercial Officer
  • Contact Info
  • Paratek Pharmaceuticals Inc.
    Phone: (617) 807-6600
    75 Park Plaza, 4th Fl.
    Boston, MA 02116
    USA
UsernamePublicRestriction

Register